Barclays PLC filed a Form 6-K with the SEC on November 02, 2026, furnishing disclosures covering total voting rights, an admission to trading, and four weekly tranches of share repurchases conducted on the London Stock Exchange during September and October 2026 as part of the buy-back programme announced on 29 July 2026.

Key Highlights

  • Total issued share capital as of 30 September 2026: 13,372,261,916 ordinary shares with voting rights, with no shares held in Treasury, according to the filing.
  • New shares admitted to trading: 2,187,284 additional ordinary shares (ISIN GB0031348658) were admitted to the London Stock Exchange's Main Market covering 1 September 2026 to 30 September 2026.
  • Aggregate buy-back as of the week ending 9 October 2026: Barclays reported purchasing 161,192,083 ordinary shares in aggregate since 29 July 2026 at a volume weighted average price of 484.4201p per share.
  • Weekly repurchase volumes: The filing discloses four weekly batches, with daily share purchases ranging from 2,242,288 to 4,110,397 shares across the period 28 September to 16 October 2026.
  • Executing broker: All purchases were made through Citigroup Global Markets Limited on behalf of Barclays PLC for cancellation.
  • Post-cancellation share capital (as of Exhibit 5): Following the week ending 16 October 2026 cancellations, issued share capital was reported as 13,337,562,645 ordinary shares, equal to total voting rights.

Barclays October 2026 Buy-Back Tranches and Voting Rights Update

According to the filing, Barclays PLC notified the market under the FCA's Disclosure Guidance and Transparency Rule 5.6.1R that its issued share capital stood at 13,372,261,916 ordinary shares as of 30 September 2026, with no shares held in Treasury. The filing states this figure may be used as the denominator by shareholders calculating notification obligations under FCA transparency rules. Separately, Barclays disclosed that 2,187,284 ordinary shares were admitted to trading on the London Stock Exchange's Main Market during September 2026, bringing the total admitted to 13,372,261,916 shares, confirmed as fungible with existing shares.

The filing covers four weekly transaction disclosures. In the week ending 2 October 2026 (Exhibit 3), Barclays purchased a total of 16,157,448 ordinary shares across five trading days, with daily volume weighted average prices ranging from 441.4308p to 464.7887p. Following those cancellations, issued share capital was reported at 13,366,146,890. In the week ending 9 October 2026 (Exhibit 4), a further 15,814,252 shares were purchased, with daily volume weighted average prices between 425.7496p and 449.4817p, reducing issued share capital to 13,351,398,273. The filing states that since the programme began on 29 July 2026, 161,192,083 shares had been purchased in aggregate at a volume weighted average price of 484.4201p.

In the week ending 16 October 2026 (Exhibit 5), Barclays reported purchasing five further daily tranches totalling 14,151,772 shares, with daily volume weighted average prices between 432.6255p and 439.5994p, reducing issued share capital to 13,337,562,645. All purchases were made through Citigroup Global Markets Limited and the company stated it intends to cancel all repurchased shares. A sixth exhibit covering the week ending 26 October 2026 is listed in the filing index but its content was not included in the provided text.

What Was Disclosed

Barclays PLC disclosed its September 2026 total voting rights, an admission to trading of 2,187,284 new shares, and weekly own-share purchase data for late September through mid-October 2026, conducted under a buy-back announced 29 July 2026.